findmyKOL
Clinical trialNCT05824988RecruitingObservational

Drug Exposure and Minimum Inhibitory Concentration in the Treatment of MAC Lung Disease

SponsorShanghai Pulmonary Hospital, Shanghai, ChinaEnrollment100Mycobacterium Avium ComplexMycobacterium Avium-Intracellulare InfectionGram-Positive Bacterial InfectionsMycobacterium Infections
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Shanghai Pulmonary Hospital

    Shanghai, China

    Li Wang, MD, PhDYidian Liu, MD, PhD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
14 Apr 2023
Primary completion
31 Oct 2025
Completion
31 Oct 2026
Last update posted
22 Jan 2024
Registered enrollment
100
Registry id
NCT05824988

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.